Bell, Jimmy,Thomas, Elizabeth Louise,Brody, Leigh,Arisoylu, Meliz Sahuri,Miller, Andrew,Frost, Gary
申请号：
AU2013308245
公开号：
AU2013308245B2
申请日:
2013.08.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention concerns nanoparticle formulations suitable for the delivery of one or more therapeutic agents, the formulations comprising: a cationic cholesterol derivative； a neutral phospholipid； cholesterol or a neutral cholesterol derivative； and a saturated fatty acid, PEGylated neutral derivative of phosphatidylethanolamine or phosphatidylcholine.
